Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
VPS26A pseudogene 1 is a pseudogene related by sequence similarity to VPS26A, which codes for a protein component of the retromer complex involved in endosomal protein sorting. As a pseudogene, VPS26AP1 is generally considered non-coding and does not encode a functional protein. It is not recognized as a receptor, enzyme, transporter, or direct therapeutic target and does not possess a known role in disease biology, drug interaction, or biomarker development. VPS26AP1 is explicitly labeled as a "pseudogene" in multiple resources. Pseudogenes are often remnants of once-functional genes but are typically non-functional due to mutations or lack of regulatory elements required for expression. The functional gene closely related to this pseudogene, VPS26A, encodes a subunit of the retromer complex with roles in endosomal sorting and trafficking, but there is no evidence that the pseudogene itself participates in these processes. There is no literature support for VPS26AP1 as a therapeutic target, nor are there known biological or disease roles, interacting drugs, mechanisms of action, or safety concerns. "VPS26A pseudogene 1" is not a therapeutic target or functional molecule; if a functional retromer complex component is needed as a target, the correct entry should be "Vacuolar protein sorting-associated protein 26A (VPS26A)".
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on VPS26A pseudogene 1 (VPS26AP1).